Literature DB >> 21670677

Disorders of selenium metabolism and selenoprotein function.

Ulrich Schweizer1, Nora Dehina, Lutz Schomburg.   

Abstract

PURPOSE OF REVIEW: Inborn errors of metabolism are increasingly recognized as underlying causes in pediatric diseases. Selenium and selenoproteins have only recently been identified as causes of inherited defects. Respective case reports have broadened our understanding of selenoprotein function and their developmental importance. This review presents the characterized defects and tries to attract attention to the spectrum of potential phenotypes. RECENT
FINDINGS: The characterization of patients with inherited mutations in selenoprotein N has corroborated the physiological importance of selenium for muscle function. Individuals with inherited defects in selenocysteine insertion sequence (SECIS)-binding protein 2 display a syndrome of selenoprotein-related defects including abnormal thyroid hormone metabolism, delayed bone maturation, and other more individual phenotypes. The recent identification of mutations in selenocysteine synthase causing progressive cerebello-cerebral atrophy underlines the central role of selenoproteins in brain development and protection from neurodegeneration.
SUMMARY: The spectrum of diseases related to inborn defects of selenium utilization, transport, and metabolism is expanding. However, only few examples are already known, resulting from defects in one selenoprotein gene and two genes involved in selenoprotein biosynthesis, respectively. Complex syndromes with impaired muscle function, stunted growth, neurosensory and/or immune defects may point to the involvement of impaired selenium metabolism and selenoprotein function, necessitating specific diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670677     DOI: 10.1097/MOP.0b013e32834877da

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  16 in total

Review 1.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Effects of acclimation salinity on the expression of selenoproteins in the tilapia, Oreochromis mossambicus.

Authors:  Lucia A Seale; Christy L Gilman; Benjamin P Moorman; Marla J Berry; E Gordon Grau; Andre P Seale
Journal:  J Trace Elem Med Biol       Date:  2014-04-24       Impact factor: 3.849

Review 3.  Understanding selenoprotein function and regulation through the use of rodent models.

Authors:  Marina V Kasaikina; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2012-03-13

Review 4.  On elongation factor eEFSec, its role and mechanism during selenium incorporation into nascent selenoproteins.

Authors:  Miljan Simonović; Anupama K Puppala
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-17       Impact factor: 3.770

Review 5.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

6.  Mice lacking selenoprotein P and selenocysteine lyase exhibit severe neurological dysfunction, neurodegeneration, and audiogenic seizures.

Authors:  China N Byrns; Matthew W Pitts; Christy A Gilman; Ann C Hashimoto; Marla J Berry
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

Review 7.  Selenoproteins in nervous system development and function.

Authors:  Matthew W Pitts; China N Byrns; Ashley N Ogawa-Wong; Penny Kremer; Marla J Berry
Journal:  Biol Trace Elem Res       Date:  2014-07-01       Impact factor: 3.738

8.  Secisbp2 is essential for embryonic development and enhances selenoprotein expression.

Authors:  Sandra Seeher; Tarik Atassi; Yassin Mahdi; Bradley A Carlson; Doreen Braun; Eva K Wirth; Marc O Klein; Nathalie Reix; Angela C Miniard; Lutz Schomburg; Dolph L Hatfield; Donna M Driscoll; Ulrich Schweizer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

9.  Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients.

Authors:  Hellmuth A Meyer; Tobias Endermann; Carsten Stephan; Mette Stoedter; Thomas Behrends; Ingmar Wolff; Klaus Jung; Lutz Schomburg
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P.

Authors:  Kostja Renko; Janine Martitz; Sandra Hybsier; Bjoern Heynisch; Linn Voss; Robert A Everley; Steven P Gygi; Mette Stoedter; Monika Wisniewska; Josef Köhrle; Vadim N Gladyshev; Lutz Schomburg
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.